Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.19.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating expenses:        
Research and development $ 6,392 $ 3,754 $ 16,633 $ 13,193
General and administrative 716 927 1,835 1,913
Loss from operations (7,108) (4,681) (18,468) (15,106)
Interest income (126) (24) (217) (72)
Net Loss $ (6,982) $ (4,657) $ (18,251) $ (15,034)
Net loss per common share outstanding, basic and diluted $ (0.43) $ (0.45) $ (1.21) $ (1.48)
Weighted average number of common shares outstanding, basic and diluted 16,314,763 10,251,950 15,035,811 10,176,062